ம்ட்கஷ ஆரோக்கியம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ம்ட்கஷ ஆரோக்கியம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ம்ட்கஷ ஆரோக்கியம் Today - Breaking & Trending Today

Global Molecular Diagnostics for Cancer Markets Report 2021-2025: Companion Diagnostics and Liquid Biopsy Drive Market Growth while Lowering Costs; COVID-19 Causes Resources Shift


7 Molecular Diagnostics Recent Developments
7.1 Recent Developments - Importance and How to Use This Section
7.1.1 Importance of These Developments
7.1.2 How to Use This Section
7.2 Nucleix to Invest in Early-Stage Lung Cancer Dx
7.3 Invitae to Acquire Genosity for $200M
7.4 Bio-Techne Obtains CE Mark for Exosomal Liquid Biopsy Prostate Test
7.5 Agilent Technologies to Acquire Liquid Biopsy Firm Resolution Bioscience
7.6 Natera Revenues Grow 35 Percent
7.7 AnchorDx Closes $40M Financing Round
7.8 Exact Sciences Strategy for End-to-End Cancer Testing
7.9 Genomics England: Whole Genome Sequencing for Cancer Patients to Launch
7.10 Singlera Genomics Closes $150M Funding for Cancer Screening
7.11 Biocartis GeneproDx, Endpoint Health Collaborate on Tests for Idylla Platform ....

United States , New York , Miltenyi Biotec , Yourgene Elucigene , Qiagen Gmbh , Sysmex Inostics , Bristol Myers Squibb , Siemens Healthineers , Biocartis Geneprodx , Laura Wood , Academic Research Lab , Testing Lab , Mdx Companion Dx Development , Sciences Strategy For Cancer Testing , Technology Development , Us Medicare Expenditures For Laboratory Testing , Singlera Genomics Inc , Physician Lab , Mdx Clinical Laboratory , Servier Sign Liquid Biopsy Services Deal , Enzo Life Sciences Inc , Office Hours Call , Biodesix Inc , Datar Cancer Genetics , Fluidigm Corp , Accuragen Inc ,

Global Cancer Genomic Cancer Panel and Profiling (Germline/Somatic) Markets to 2025: Factors Driving Growth - Level of Care, Companion Dx, Immuno-oncology, Liability, Aging Population


3.3.2 Bioinformatics Plays a Role
3.4 Diagnostic Technology Development
3.4.2 Single Cell Genomics Changes the Picture
3.4.3 Pharmacogenomics Blurs Diagnosis and Treatment
3.4.4 CGES Testing, A Brave New World
3.4.5 Biochips/Giant magnetoresistance based assay
4. Cancer Panels & Profiles Recent Developments
4.1 Recent Developments - Importance and How to Use This Section
4.1.1 Importance of These Developments
4.1.2 How to Use This Section
Biocartis Collaborating With GeneproDx, Endpoint Health on Tests for Idylla Platform
Wales to Routinely Screen Cancer Patients With Yourgene Elucigene Test
Metastatic Cancer Markers Identified in Clinical WGS Study
Stitch Bio Bets on CRISPR Tech
Bayer, LifeLabs Launch Free NTRK Genetic Testing Program
Foundation Medicine Liquid Biopsy Gets FDA Approval for Multiple Companion Dx ....

United States , Miltenyi Biotec , Yourgene Elucigene , Siemens Healthineers , Qiagen Gmbh , Sysmex Inostics , Laura Wood , Academic Research Lab , Testing Lab , Public National , Central Lab , Technology Development , Singlera Genomics Inc , Invitae Corporation , Physician Office Lab , Enzo Life Sciences Inc , Office Hours Call , Biodesix Inc , Datar Cancer Genetics , Fluidigm Corp , Accuragen Inc , Business Development Staff , Genefirst Ltd , Bioneer Corporation , Genomics Co , Thermo Fisher Scientific Inc ,